Medical Journals

An Osteopontin Fragment is Essential for Tumor Cell Invasion in Hepatocellular Carcinoma.

Authors:
  • Takafuji V
  • Forgues M
  • Unsworth E
  • Goldsmith P
  • Wang X W

From: Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-4258, USA.

Oncogene

  • Publish Date: Sep 2007
  • ISSN: 0950-9232
  • Volume: 26
  • Issue: 44
  • Pages: 6361-71
  • Medium: Print
  • Language: English
  • Citation (JAMA): Takafuji V, Forgues M, Unsworth E, et al. An Osteopontin Fragment is Essential for Tumor Cell Invasion in Hepatocellular Carcinoma.. Oncogene Sep 2007;26:6361-71

Abstract

Tumor cell invasion is a primary event in the metastatic progression of hepatocellular carcinoma (HCC). Our recent results indicate a concordant elevated expression of osteopontin (OPN) and matrix metalloproteinase-9 (MMP-9) in primary metastatic HCC. This study hypothesizes an MMP-9-directed cleavage of OPN that biologically contributes to HCC metastasis. We found that MMP-9 cleaved OPN into specific fragments in vitro, of which three could be identified by Edman degradation amino-acid sequencing. One of these fragments (OPN-5 kDa, residues 167-210) induced low-metastatic HCC cellular invasion via CD44 receptors, which was effectively blocked by the addition of small peptides within the region of OPN-5 kDa. Increased expression of an OPN splice variant (OPN-c) was associated with clinical metastatic HCC. Overexpression of OPN-c with physiological levels of MMP-9 enhanced cellular invasion and coincided with elevated OPN-5 kDa levels. Our data suggest that an alternative splicing event (OPN-c) promotes extracellular cleavage of OPN by MMP-9, thus releasing a distinct region of OPN (OPN-5 kDa) that is essential for HCC cellular invasion and appears to correlate with metastatic potential. The findings of this study may help to improve advanced-stage HCC prognosis and suggest the utility of small peptides for novel therapies.

Mesh Headings (Keywords): Alternative Splicing, Animals, Antigens, CD44, Blotting, Western, Carcinoma, Hepatocellular, Cell Adhesion, Cell Movement, Chromatography, Affinity, Disease Progression, Gene Expression Regulation, Neoplastic, Humans, Immunoprecipitation, Liver Neoplasms, Matrix Metalloproteinase 9, Neoplasm Invasiveness, Osteopontin, Peptide Fragments, Prognosis, RNA, Messenger, Rabbits, Reverse Transcriptase Polymerase Chain Reaction, Transfection


Check for Full Text / PubMed Unique Identifier (PMID): 17452979


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.